A detailed history of Aqr Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 309,119 shares of EW stock, worth $20.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
309,119
Previous 342,874 9.84%
Holding current value
$20.2 Million
Previous $32.8 Million 12.86%
% of portfolio
0.04%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $2.85 Million - $3.18 Million
-33,755 Reduced 9.84%
309,119 $28.6 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $5.13 Million - $6.76 Million
-70,714 Reduced 17.1%
342,874 $32.8 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $8.9 Million - $11.2 Million
144,166 Added 53.51%
413,588 $31.5 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $14.5 Million - $19.6 Million
-209,826 Reduced 43.78%
269,422 $18.7 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $7.44 Million - $8.62 Million
-91,339 Reduced 16.01%
479,248 $45.2 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $6.1 Million - $6.95 Million
82,192 Added 16.83%
570,587 $47.2 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $2.64 Million - $3.38 Million
-38,616 Reduced 7.33%
488,395 $36.4 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $5.87 Million - $7.65 Million
71,289 Added 15.64%
527,011 $43.5 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $1.76 Million - $2.61 Million
-20,318 Reduced 4.27%
455,722 $43.1 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $15.1 Million - $19.1 Million
-148,559 Reduced 23.78%
476,040 $56 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $292,942 - $359,892
2,754 Added 0.44%
624,599 $80.9 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $7.15 Million - $8.53 Million
-69,469 Reduced 10.05%
621,845 $70.4 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $15.7 Million - $19.6 Million
-187,193 Reduced 21.31%
691,314 $71.6 Million
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $12.6 Million - $14.6 Million
-160,631 Reduced 15.46%
878,507 $73.3 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $30.3 Million - $38.5 Million
-422,552 Reduced 28.91%
1,039,138 $93.1 Million
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $50.4 Million - $65.5 Million
-749,599 Reduced 33.9%
1,461,690 $116 Million
Q2 2020

Aug 17, 2020

BUY
$57.54 - $76.95 $82.7 Million - $111 Million
1,437,876 Added 185.91%
2,211,289 $149 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $3.5 Million - $5.4 Million
66,714 Added 9.44%
773,413 $146 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $5.56 Million - $6.36 Million
-77,532 Reduced 9.89%
706,699 $164 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $11.8 Million - $14.4 Million
-190,923 Reduced 19.58%
784,231 $172 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $3.81 Million - $4.4 Million
68,314 Added 7.53%
975,154 $180 Million
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $4.18 Million - $5.59 Million
87,218 Added 10.64%
906,840 $172 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $22.1 Million - $27.1 Million
475,178 Added 137.96%
819,622 $126 Million
Q3 2018

Nov 15, 2018

BUY
$45.7 - $58.03 $6.07 Million - $7.71 Million
132,918 Added 62.84%
344,444 $60 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $3.2 Million - $3.87 Million
75,440 Added 55.44%
211,526 $30.8 Million
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $811,485 - $1.04 Million
21,820 Added 19.1%
136,086 $19 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $564,124 - $657,616
-16,695 Reduced 12.75%
114,266 $12.9 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $4.75 Million - $5.09 Million
130,961
130,961 $14.3 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.